Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250823066963N1Phase 2Completed
Phase 2, randomised, double-blind trial of methylprednisolone in Simple Bone Cyst (SBC) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Radiographic healing, Ossification level and 3 more. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250823066963N1.